🇺🇸 FDA
Patent

US 10261083

Compositions and methods for detecting protease activity in biological systems

granted A61KA61K47/6849A61K47/6855

Quick answer

US patent 10261083 (Compositions and methods for detecting protease activity in biological systems) held by CytomX Therapeutics, Inc. expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CytomX Therapeutics, Inc.
Grant date
Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K47/6849, A61K47/6855, A61K47/6889, A61K49/0021